Nigeria: Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored By IAVI

[Nigeria Health Watch] The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidate
Source: AllAfrica News: Health and Medicine - Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news